Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Hologic, Inc.    HOLX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Hologic, Inc. : Hologic to Present at Three Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2013 | 01:05pm CET

BEDFORD, Mass., May 9, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that company management will participate in the following investor conferences:

    --  Glenn Muir, Executive Vice President and Chief Financial Officer, will
        present at:
        --  The Bank of America Merrill Lynch 2013 Health Care Conference in Las
            Vegas, Nevada on Tuesday, May 14, 2013 at 11:40 a.m. Eastern Time
            (ET).
        --  The William Blair 33(rd) Annual Growth Stock Conference in Chicago,
            Illinois on Wednesday, June 12, 2013 at 1:40 p.m. ET.
    --  Rob Cascella, President and Chief Executive Officer, will present at:
        --  The Goldman Sachs 34(th) Annual Global Healthcare Conference in
            Rancho Palos Verdes, California on Wednesday, June 12, 2013 at 2:20
            p.m. ET.

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.:

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.


    Contacts:


    Deborah R. Gordon                  Al Kildani

    Vice President, Investor Relations Senior Director, Investor Relations

    (781) 999-7716                     (858) 410-8653

    deborah.gordon@hologic.com         al.kildani@hologic.com

SOURCE Hologic, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HOLOGIC, INC.
12/01 HOLOGIC : Patent Issued for Detecting and Quantifying Patient Motion during Tomo..
11/28 HOLOGIC, INC. (NASDAQ : HOLX) Files An 8-K Departure of Directors or Certain Off..
11/28 HOLOGIC INC : Change in Directors or Principal Officers (form 8-K)
11/25 HOLOGIC : to Showcase Award-Winning Breast Screening and Interventional Solution..
11/22 HOLOGIC : Patent Issued for System for Improved Tissue-Handling and in Line Anal..
11/22 HOLOGIC : Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablatio..
11/21 HOLOGIC : Assigned Patent
11/18 HOLOGIC : American Society for Radiation Oncology (ASTRO) Publishes New Evidence..
11/17 HOLOGIC : Obtains Canadian Approval for Aptima® Hepatitis C and B Quant Assays
11/17 HOLOGIC : Management's Discussion and Analysis of Financial Condition and Result..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
11/02DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
11/29 HOLX : 4Q Results And FY17 Guidance Beat Expectations
11/03 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
11/02 Hologic (HOLX) Q4 2016 Results - Earnings Call Transcript
11/02 Hologic fiscal Q4 top line up 3%; non-GAAP earnings up 15%
11/02 Hologic beats by $0.02, beats on revenue